Aurobindo Pharma
BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01037 | SECTOR: Major DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
15.67Net Income/employee - trailing 12 month
17,63,882.00Revenue/employee - most recent fiscal year
1,35,48,860.00Return on investment - most recent fiscal year
7.12Return on average assets - most recent fiscal year
5.22Receivables turnover - most recent fiscal year
5.84Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.53Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
1,77,78,640.00Return on average assets - 5 year average
9.84Net Income/employee - most recent fiscal year
10,50,777.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.67Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
7.50Return on investment - 5 year average
14.92